Non-Hodgkin’s lymphoma arising in patients treated for Hodgkin’s disease in the BNLI: A 20-year experience

Twenty-two of 3033 patients with Hodgkin’s disease (HD) randomised into the clinical trials of the BNLI have developed non-Hodgkin’s lymphomas (NHLs) at periods up to 16 years after presentation (1 simultaneous and 1 composite), giving an incidence of 0.7%. The frequency of NHL varied from 3.8% in lymphocyte-predominant HD to 0.3% in nodular sclerosing HD. In this series, 16 patients developed high-grade NHL (12 B cell; 4 peripheral T cell) and 6 developed low-grade NHL (all B cell). The histological subtype of NHL did not appear to be related to initial histological subtype of HD or the treatment received. In histological subtypes other than lymphocyte predominant, there was commonly evidence of immunosuppression in the form of low presentation lymphocyte counts, advanced stage and systemic (B) symptoms. The results suggest that these patients have a propensity for lymphoproliferative disorders, possibly associated with some immune deficiency and the subsequent development of NHL is not treatment related. The findings also emphasise how important it is to biopsy recurrent disease.

[1]  J. Chan,et al.  Large B-cell lymphomas with a high content of reactive T cells. , 1989, Human pathology.

[2]  C. Fellbaum,et al.  Nodular paragranuloma can transform into high-grade malignant lymphoma of B type. , 1989, Human pathology.

[3]  C. Fellbaum,et al.  Morphological and immunohistochemical investigation of non‐Hodgkin's lymphoma combined with Hodgkin's disease , 1989, Histopathology.

[4]  E. Jaffe,et al.  Lymphocyte predominant Hodgkin's disease nodular subtype with coexistent "large cell lymphoma". Histological progression or composite malignancy? , 1988, The American journal of surgical pathology.

[5]  P. Isaacson,et al.  T‐Cell-Rich B‐Cell Lymphoma , 1988, The American journal of surgical pathology.

[6]  P. Hall,et al.  Value of CD15 immunostaining in diagnosing Hodgkin's disease: a review of published literature. , 1987, Journal of clinical pathology.

[7]  AlisonJ. Cheyne,et al.  SECOND MALIGNANCIES AND HODGKIN'S DISEASE , 1987, The Lancet.

[8]  K. Maclennan,et al.  Systemic disturbance in Hodgkin's disease and its relation to histopathology and prognosis (BNLI report No. 30). , 1987, Clinical radiology.

[9]  S. Poppema,et al.  Nodular lymphocyte predominance type of Hodgkin's disease is a germinal center lymphoma. , 1986, Laboratory investigation; a journal of technical methods and pathology.

[10]  A. Norton,et al.  Monoclonal antibody (UCHL1) that recognises normal and neoplastic T cells in routinely fixed tissues. , 1986, Journal of clinical pathology.

[11]  T. Takami,et al.  Two distinct antigen systems in human B lymphocytes: identification of cell surface and intracellular antigens using monoclonal antibodies. , 1984, Clinical and experimental immunology.

[12]  U. Almagro,et al.  Hodgkin's disease followed by mycosis fungoides in the same patient case report and literature review , 1984, Cancer.

[13]  C. Jacquillat,et al.  Non‐Hodgkin's lymphoma occurring after hodgkin's disease four new cases and a review of the literature , 1984, Cancer.

[14]  K. Franssila,et al.  Hodgkin's disease, lymphocytic predominance nodular. Increased risk for subsequent non‐Hodgkin's lymphomas , 1983, Cancer.

[15]  J. Armitage,et al.  Second lymphoid malignant neoplasms occurring in patients treated for Hodgkin's disease. , 1983, Archives of internal medicine.

[16]  R. Harlow,et al.  T‐cell non‐hodgkin's lymphoma after radiotherapy and chemotherapy for hodgkin's disease , 1981, Cancer.

[17]  S. Hsu,et al.  Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. , 1981, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[18]  J. Diebold,et al.  Atypical T‐cell leukemia terminating Hodgkin's disease , 1979, Cancer.

[19]  S. Rosenberg,et al.  Occurrence of non-Hodgkin's lymphoma after therapy for Hodgkin's disease. , 1979, The New England journal of medicine.

[20]  S. Karp,et al.  Non-Hodgkin's lymphoma following radiotherapy for Hodgkin's disease. , 1986, Clinical radiology.

[21]  R. Hartsock,et al.  Pathology Panel for Lymphoma Clinical Studies: a comprehensive analysis of cases accumulated since its inception. , 1982, Journal of the National Cancer Institute.

[22]  A. Jelliffe,et al.  The evolution of the British National Lymphoma Investigation (Report no 5). , 1981, Clinical radiology.